Unno M - Search Results

1

Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Lwin TM, Higuchi T, Kiyuna T, Miyake M, Oshiro H, Bouvet M, Unno M, Hoffman RM. Kawaguchi K, et al. Among authors: unno m. Cell Cycle. 2018;17(7):868-873. doi: 10.1080/15384101.2018.1445907. Epub 2018 May 21. Cell Cycle. 2018. PMID: 29623758 Free PMC article.

2

Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas.

Ishida M, Egawa S, Kawaguchi K, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Katayose Y, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T. Ishida M, et al. Among authors: unno m. Pancreatology. 2008;8(6):577-82. doi: 10.1159/000159844. Epub 2008 Sep 29. Pancreatology. 2008. PMID: 18824881

3

Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells.

Ohmine K, Kawaguchi K, Ohtsuki S, Motoi F, Egawa S, Unno M, Terasaki T. Ohmine K, et al. Among authors: unno m. Pharm Res. 2012 Jul;29(7):2006-16. doi: 10.1007/s11095-012-0728-2. Epub 2012 Mar 15. Pharm Res. 2012. PMID: 22419259

4

DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells.

Saiki Y, Yoshino Y, Fujimura H, Manabe T, Kudo Y, Shimada M, Mano N, Nakano T, Lee Y, Shimizu S, Oba S, Fujiwara S, Shimizu H, Chen N, Nezhad ZK, Jin G, Fukushige S, Sunamura M, Ishida M, Motoi F, Egawa S, Unno M, Horii A. Saiki Y, et al. Among authors: unno m. Biochem Biophys Res Commun. 2012 Apr 27;421(1):98-104. doi: 10.1016/j.bbrc.2012.03.122. Epub 2012 Apr 3. Biochem Biophys Res Commun. 2012. PMID: 22490663

5

[Efficacy of neoadjuvant chemotherapy for resectable pancreatic carcinoma].

Motoi F, Kawaguchi K, Aoki T, Kudo K, Yabuuchi S, Fukase K, Mizuma M, Sakata N, Otsutomo S, Morikawa T, Hayashi H, Nakagawa K, Okada T, Yoshida H, Naitoh T, Katayose Y, Egawa S, Unno M. Motoi F, et al. Among authors: unno m. Gan To Kagaku Ryoho. 2013 Nov;40(12):1632-6. Gan To Kagaku Ryoho. 2013. PMID: 24393872 Japanese.

6

[A case of curatively resected locally advanced pancreatic cancer with combined resection of the portal vein and common hepatic artery after neoadjuvant chemotherapy].

Kawaguchi K, Motoi F, Yokoyama S, Takemura S, Doi T, Nozawa Y, Fujishima F, Unno M, Kuroda F. Kawaguchi K, et al. Among authors: unno m. Gan To Kagaku Ryoho. 2013 Nov;40(12):1875-7. Gan To Kagaku Ryoho. 2013. PMID: 24393951 Japanese.

7

Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects.

Komura T, Miura K, Shirasaka T, Ohnuma S, Shimada M, Kajiwara T, Fujishima F, Philchenkov A, Nakagawa K, Kudoh K, Haneda S, Toshima M, Kohyama A, Musha H, Naitoh T, Shibata C, Unno M. Komura T, et al. Among authors: unno m. Int J Clin Oncol. 2015 Feb;20(1):117-25. doi: 10.1007/s10147-014-0699-x. Epub 2014 May 8. Int J Clin Oncol. 2015. PMID: 24802097

8

[A case of pancreatic cancer with local recurrence and liver metastases eight years after surgery].

Taniguchi H, Mizuma M, Motoi F, Abe T, Okada R, Kawaguchi K, Karasawa H, Masuda K, Yabuuchi S, Fukase K, Sakata N, Okada T, Nakagawa K, Hayashi H, Morikawa T, Yoshida H, Naito T, Katayose Y, Egawa S, Unno M. Taniguchi H, et al. Among authors: unno m. Gan To Kagaku Ryoho. 2014 Nov;41(12):2193-5. Gan To Kagaku Ryoho. 2014. PMID: 25731467 Review. Japanese.

9

Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.

Douchi D, Ohtsuka H, Ariake K, Masuda K, Kawasaki S, Kawaguchi K, Fukase K, Oikawa M, Motoi F, Naitoh T, Katayose Y, Egawa S, Unno M. Douchi D, et al. Among authors: unno m. Cancer Lett. 2015 Aug 28;365(1):132-40. doi: 10.1016/j.canlet.2015.05.023. Epub 2015 Jun 3. Cancer Lett. 2015. PMID: 26047573

10

Quantitative Targeted Proteomics of Pancreatic Cancer: Deoxycytidine Kinase Protein Level Correlates to Progression-Free Survival of Patients Receiving Gemcitabine Treatment.

Ohmine K, Kawaguchi K, Ohtsuki S, Motoi F, Ohtsuka H, Kamiie J, Abe T, Unno M, Terasaki T. Ohmine K, et al. Among authors: unno m. Mol Pharm. 2015 Sep 8;12(9):3282-91. doi: 10.1021/acs.molpharmaceut.5b00282. Epub 2015 Aug 25. Mol Pharm. 2015. PMID: 26280109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

964 results

Search Page

Filters